title: Conservative management of carpal tunnel syndrome: a reexamination of steroid injection and splinting.
abstract: The awareness of carpal tunnel syndrome by the lay public has increased dramatically in recent years, with an apparent shift in patient-population presentation. We prospectively studied steroid injection and wrist splinting in 76 hands in 57 patients, presenting without advanced disease or associated medical conditions, by standard evaluation and protocol of treatment. The average age of the patients was 38 years; 50 women and 7 men were included. Follow-up examination after simultaneous steroid injection and splinting averaged 11 months. Ten hands were noted to be symptom-free at the final evaluation. Women were noted to have a significant decrease in the rate of symptom resolution when compared to men. Patients, 40 years of age or younger, were also noted to have a significant decrease in the rate of symptom resolution when compared to patients over 40 years of age. No significant differences were noted when comparing symptom duration prior to treatment or workers' compensation insurance status to final symptom resolution. Young women are the least likely to have resolution of carpal tunnel syndrome symptoms when treated conservatively.
authors.affiliation: Division of Hand, Upper Extremity, and Microvascular Surgery, Brown University School of Medicine, Rhode Island Hospital, Providence.
authors.forename: A P
authors.initials: AP
authors.lastname: Weiss
authors.forename: K
authors.initials: K
authors.lastname: Sachar
authors.forename: M
authors.initials: M
authors.lastname: Gendreau
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000367:Age Factors; D001623:Betamethasone / Q000008:administration & dosage; D002349:Carpal Tunnel Syndrome / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D011446:Prospective Studies; D012737:Sex Factors; D013165:Splints; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D001623:Betamethasone